RxDoctor Payments DataLook up a doctor →

Michael Kohen, MD

Allergy & Immunology · Daytona Beach, FLNPI 1013909951

Payments from drug & device makers

$3,566,531in general payments, 2019–2025

Across 1,997 payments — averaging $1785.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.5M
  • Eli Lilly$426K
  • Janssen Research & Development, LLC$310K
  • E.r. Squibb & Sons, L.L.C.$307K
  • Astrazeneca UK Limited$191K
  • UCB SA$175K
  • plus $608K from 54 others
$2,282in research payments, 2019–2025

Across 2 payments — averaging $1141.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie425$1,549,274
Eli Lilly58$425,638
Janssen Research & Development, LLC27$309,558
E.r. Squibb & Sons, L.L.C.49$306,920
Astrazeneca UK Limited10$191,224
UCB SA24$175,407
Amgen(2 entities)236$145,796
Kiniksa Pharmaceuticals, Ltd.189$117,734
Pfizer148$93,061
Takeda Pharmaceuticals U.S.A., Inc.30$73,446
Mitsubishi Tanabe Pharma Development America, Inc.3$57,675
Tanabe Pharma America, Inc.27$39,703
Sanofi US Services Inc.6$32,192
Kiniksa Pharmaceuticals International, PLC110$30,582
Bristol Myers Squibb9$2,849
UCB, Inc.102$2,568
Johnson & Johnson(2 entities)71$1,847
Lilly USA, LLC66$1,331
AstraZeneca(2 entities)58$1,216
Novartis56$1,175
GSK61$1,075
Sanofi29$851
Regeneron Healthcare Solutions, Inc.20$702
Octapharma USA, Inc.9$628
Radius Health, Inc.25$542
Boehringer Ingelheim27$542
ADMA Biomanufacturing LLC3$448
Aurinia Pharma U.S., Inc.16$335
CSL Behring10$258
Mallinckrodt Hospital Products Inc.10$211
Mallinckrodt Enterprises LLC9$191
Genentech USA, Inc.7$176
Grifols USA, LLC7$142
Janssen Scientific Affairs, LLC1$122
Sobi, Inc6$99
Sandoz5$74
Kaleo, Inc.4$72
Blueprint Medicines Corporation3$70
Antares Pharma, Inc.4$53
Scilex Pharmaceuticals Inc.3$51
Pacira Therapeutics, Inc.2$49
Organon2$47
Biocryst US Sales Co., LLC2$45
Insmed, Inc.2$44
Teva Pharmaceuticals USA, Inc.1$42
Actelion Pharmaceuticals US, Inc.2$40
ANI Pharmaceuticals, Inc.2$40
Pharming Healthcare, Inc.2$37
ARS Pharmaceuticals Operations, Inc.2$37
Eyevance Pharmaceuticals LLC2$35
Hikma Pharmaceuticals USA2$35
Mylan Institutional Inc.1$35
Merck2$34
Bioventus LLC2$30
Tersera Therapeutics LLC1$28
Sanofi-aventis U.S. LLC1$25
Fidia Pharma USA Inc.1$18
Alk-abello, Inc1$17
Shire North American Group Inc1$16
Medexus Pharma, Inc.1$13

How this compares

$3,566,531 in reported general payments places this provider in the 95th percentile of 204 allergy & immunology providers in Florida.

See all allergy & immunology providers in Florida →

Medicare billing

Part B allowed, 2024
$1,263,941
Medicare patients
739
Services billed
200,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Daytona Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →